FDA approves first generic of Xeloda for colon cancer

The US Food and Drug Administration has given approval to Teva Pharmaceuticals for the first generic version of Roche's colon cancer drug Xeloda.
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news